Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Express Scripts, Prime Therapeutics face more antitrust allegations

28 August 2026 · By · Wire by Fusion42

Published

28 August 2026

Topic

regulatory

◆ Sectors

Healthtech Infrastructure

◆ Geography

United States

◆ Source

Read at modernhealthcare.com →

◆ Verified

Fusion42 · 28 August 2026 · Fusion42 review

Pharmacy benefit managers Prime Therapeutics and Express Scripts face new antitrust allegations in Florida, continuing regulatory scrutiny in the sector.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ ◆ The Wire takeaway

You face increasing legal pressure if you operate in US pharmacy benefits, as regulators target top managers with antitrust suits. Adjust your compliance and customer discussions now before market access narrows.

◆ Coverage

1 source · 28 Aug 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructurepharmacy-benefit-managersantitrusthealthcare-regulationus-market